Meningococcal disease and its control.
D000917:Antibody Formation; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D002353:Carrier State; D004196:Disease Outbreaks / Q000517:prevention & control; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D008585:Meningitis, Meningococcal / Q000276:immunology / Q000517:prevention & control; D008589:Meningococcal Infections / Q000276:immunology / Q000517:prevention & control*; D008887:Military Medicine; D008911:Minocycline / Q000627:therapeutic use; D009345:Neisseria meningitidis; D011135:Polysaccharides, Bacterial; D012293:Rifampin / Q000627:therapeutic use; D018805:Sepsis / Q000276:immunology / Q000517:prevention & control; D013411:Sulfadiazine / Q000627:therapeutic use; D014481:United States
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial; D013411:Sulfadiazine; D008911:Minocycline; D012293:Rifampin